Ann Coloproctol.
2014 Jun;30(3):122-131. 10.3393/ac.2014.30.3.122.
The Unresolved Case of Sacral Chordoma: From Misdiagnosis to Challenging Surgery and Medical Therapy Resistance
- Affiliations
-
- 1Department of Surgery, Intercantonal Hospital Broye, Payerne, Switzerland.
- 2Department of Visceral Surgery, University Hospital of Lausanne (CHUV), Lausanne, Switzerland. demartines@chuv.ch
- 3Department of Surgery, Hospital Civico, Lugano, Switzerland.
- 4Department of Plastic and Reconstructive Surgery, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
- 5Department of Oncology, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
- 6Department of Orthopedics, University Hospital of Lausanne (CHUV), Lausanne, Switzerland.
- KMID: 1801630
- DOI: http://doi.org/10.3393/ac.2014.30.3.122
Abstract
- PURPOSE
A sacral chordoma is a rare, slow-growing, primary bone tumor, arising from embryonic notochordal remnants. Radical surgery is the only hope for cure. The aim of our present study is to analyse our experience with the challenging treatment of this rare tumor, to review current treatment modalities and to assess the outcome based on R status.
METHODS
Eight patients were treated in our institution between 2001 and 2011. All patients were discussed by a multidisciplinary tumor board, and an en bloc surgical resection by posterior perineal access only or by combined anterior/posterior accesses was planned based on tumor extension.
RESULTS
Seven patients underwent radical surgery, and one was treated by using local cryotherapy alone due to low performance status. Three misdiagnosed patients had primary surgery at another hospital with R1 margins. Reresection margins in our institution were R1 in two and R0 in one, and all three recurred. Four patients were primarily operated on at our institution and had en bloc surgery with R0 resection margins. One had local recurrence after 18 months. The overall morbidity rate was 86% (6/7 patients) and was mostly related to the perineal wound. Overall, 3 out of 7 resected patients were disease-free at a median follow-up of 2.9 years (range, 1.6-8.0 years).
CONCLUSION
Our experience confirms the importance of early correct diagnosis and of an R0 resection for a sacral chordoma invading pelvic structures. It is a rare disease that requires a challenging multidisciplinary treatment, which should ideally be performed in a tertiary referral center.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Sacral Chordoma: Challenging for Resection Margin
- Sacrococcygeal Chordoma
- The Single Posterior Approach for Resection of Sacral Chordoma: A Case Report
- Spinopelvic Reconstruction with Femoral Allograft and Vertical Rectus Abdominis Myocutaneous Flap after Total Sacrectomy in Recurrent Sacral Chordoma: A Case Report
- A Case of Giant Sacral Chordoma
